Costs Associated with Febrile Neutropenia in the US

Author： Michels Shannon L.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.9, 2012-09, pp. : 809-823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Febrile neutropenia costly in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antineoplastics: Febrile neutropenia associated with malaria: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Hold the antibacterials in febrile neutropenia

By  

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective

By Cosler Leon E.   Eldar-Lissai Adi  

PharmacoEconomics, Vol. 25, Iss. 4, 2007-01 ,pp. : 343-351

Adis International

Access to resources Recommend Favorite

Docetaxel: Neutropenia and febrile neutropenia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite